Correlia Biosystems

Correlia Biosystems, an inactive UC Berkeley spinoff located in Berkeley, California, focused on developing advanced microscale tools designed to expedite the quantification of biomolecules. Their core innovation, the "SimpleScan" technology, aimed to unlock novel biological insights from minimal sample volumes (one microliter). This technology offered rapid results, facilitating dynamic monitoring of protein expression profiles, moving beyond traditional endpoint measurements. The intended applications spanned a broad spectrum, from enabling next-generation proteomic datasets to facilitating point-of-care diagnostics. However, the company is no longer active.